The Development of Antiretroviral Therapy Order Set for Admitted Adult HIV-Infected Patients
Uraiwan Akanit, Pharm D, BCPS; Benjamin Staley, PharmD; Jennifer W. Janelle, MD, AAHIVS; Zoe Muller, MD; Emily C. Huesgen, Pharm D, BCACP, AAHIVP; Sam J Borgert, Pharm D; & Ann Snyder Franklin, PharmD, MEd, BCPS

Purpose: The purpose of the project was to develop and implement an HIV order set to minimize medication prescribing errors. Methods: A consensus panel of 7 specialists participated in the order-set content and design for EPIC. The order set and policies were approved by the institutional pharmacy and therapeutics committee. A post-implementation consensus evaluated the HIV order set for ease of use, accuracy, and completeness. Results: An IT pharmacist developed the HIV order-set. To create the enhanced decision support tool and functionality in EPIC approximate builder time was 40 hours. Post-evaluation showed that an unavailable product such as ritonavir capsule is still orderable in the orderset. Many new products need to be added to the order-set due to the fast growing in the antiretroviral drug discovery area. Conclusion: In order to design the order-set aiming to prevent the chance of virological failure in the inpatient with HIV, it was important to strategically identify a team including both inpatient and outpatient representatives for the development and evaluation of the HIV order-set. It was critical to have an IT pharmacist specialist to support the design of building necessary and facilitate the update practice guidelines with the clinical team.

Full Text: PDF     DOI: 10.15640/ijmp.v4n2a1